Hogan Lovells represented Kaiser Foundation Hospitals on the deal. McDermott Will & Emery represented Geisinger Health. Risant Health completed its acquisition of Geisinger, a US$10 billion health...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented Applied DNA Sciences, Inc., while Harter Secrest & Emery represented the placement agent in the transaction. Applied DNA Sciences, Inc. (Applied...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented Trio Petroleum Corp. in the offering. Trio Petroleum Corp., an oil and gas exploration and development company focused on strategic, high-growth...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented Inhibikase Therapeutics, Inc. in the transaction. Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented ThinkEquity LLC as placement agent in the transaction. TECO 2030 AS announced a $10 million strategic investment. The investment was in the form...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Murphy Canyon Acquisition Corp., while Thompson Hine represented Conduit on the deal. Murphy Canyon Acquisition Corp. (Nasdaq: MURF), a publicly traded special...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Splash Beverage Group in the transaction. Splash Beverage Group, Inc. (NYSE American: SBEV), a portfolio company of leading beverage brands, executed an underwritten public...
You must be a Standard 1 Year member to access this content.
Pryor Cashman advised Crown Electrokinetics, while Sichenzia Ross Ference represented Roth Capital Partners, as sole book-running manager, in the offering. Crown Electrokinetics Corp. executed a $1 million...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Spartan Capital Securities in the offering. Lytus Technologies Holdings PTV. Ltd (NASDAQ: LYT), a platform technology services company, the initial public offering...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Sunshine Biopharma on the offering. Sunshine Biopharma, Inc., a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Sharps Technology in the offering. Sharps Technology, Inc. (Nasdaq: STSS and STSSW), an innovative medical device company offering patented, best-in-class, single use...
You must be a Standard 1 Year member to access this content.
